DK1490391T3 - 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring - Google Patents
11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonringInfo
- Publication number
- DK1490391T3 DK1490391T3 DK03717244T DK03717244T DK1490391T3 DK 1490391 T3 DK1490391 T3 DK 1490391T3 DK 03717244 T DK03717244 T DK 03717244T DK 03717244 T DK03717244 T DK 03717244T DK 1490391 T3 DK1490391 T3 DK 1490391T3
- Authority
- DK
- Denmark
- Prior art keywords
- pregna
- ols
- long chain
- lactone ring
- 11beta
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 125000000686 lactone group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10214180A DE10214180A1 (de) | 2002-03-27 | 2002-03-27 | 11beta-lankgettig-substituierte 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21,16alpha-Laktonring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1490391T3 true DK1490391T3 (da) | 2006-04-18 |
Family
ID=28050972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03717244T DK1490391T3 (da) | 2002-03-27 | 2003-03-27 | 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1490391B1 (da) |
| JP (1) | JP2005526805A (da) |
| AT (1) | ATE313552T1 (da) |
| AU (1) | AU2003221528A1 (da) |
| DE (2) | DE10214180A1 (da) |
| DK (1) | DK1490391T3 (da) |
| ES (1) | ES2254924T3 (da) |
| WO (1) | WO2003080641A1 (da) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1255659B (de) * | 1961-05-31 | 1967-12-07 | Abbott Lab | Verfahren zur Herstellung von Steroidlactonen |
| US3089874A (en) * | 1961-05-31 | 1963-05-14 | Abbott Lab | Steroid lactones |
| US3920634A (en) * | 1974-08-30 | 1975-11-18 | Lilly Co Eli | 2,3-Dihydroestra-1,3,5(10)-trieno (16{60 ,17{60 -{62 ) furan-17{62 ols |
| DE10048634A1 (de) * | 2000-09-27 | 2002-04-18 | Jenapharm Gmbh | 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring |
-
2002
- 2002-03-27 DE DE10214180A patent/DE10214180A1/de not_active Withdrawn
-
2003
- 2003-03-27 DK DK03717244T patent/DK1490391T3/da active
- 2003-03-27 EP EP03717244A patent/EP1490391B1/de not_active Expired - Lifetime
- 2003-03-27 ES ES03717244T patent/ES2254924T3/es not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003226 patent/WO2003080641A1/de not_active Ceased
- 2003-03-27 JP JP2003578394A patent/JP2005526805A/ja active Pending
- 2003-03-27 AU AU2003221528A patent/AU2003221528A1/en not_active Abandoned
- 2003-03-27 DE DE50302000T patent/DE50302000D1/de not_active Expired - Fee Related
- 2003-03-27 AT AT03717244T patent/ATE313552T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005526805A (ja) | 2005-09-08 |
| ATE313552T1 (de) | 2006-01-15 |
| WO2003080641A1 (de) | 2003-10-02 |
| EP1490391A1 (de) | 2004-12-29 |
| DE50302000D1 (de) | 2006-01-26 |
| DE10214180A1 (de) | 2003-10-16 |
| EP1490391B1 (de) | 2005-12-21 |
| ES2254924T3 (es) | 2006-06-16 |
| AU2003221528A1 (en) | 2003-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| DE60144392D1 (de) | Antivirale mittel | |
| DE69830504D1 (de) | Antithrombotische mitteln | |
| HN2003000348A (es) | Compuestos de benzofurano, composiciones y metodos para tratamiento y profilaxis de infeccion virales de hepatitis c y enfermedades asociadas. | |
| CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
| AR026410A1 (es) | ''2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas sustituidas, y las composiciones y metodos farmaceuticos relacionados | |
| AP2002002637A0 (en) | Novel piperazine | |
| DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
| DE69919212D1 (de) | Aromatische amiden | |
| CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
| ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| ATE289810T1 (de) | Ecteinascidinderivate | |
| SE0302116D0 (sv) | Novel compounds | |
| TR200402454T4 (tr) | C-4 karbonat taksanlar. | |
| ATE280767T1 (de) | Antidiabetische thiazolidindione und ihre herstellung | |
| DE60114640D1 (en) | Antithrombosemittel | |
| GB0212410D0 (en) | Organic compounds | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| DE60107832D1 (en) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
| MY125378A (en) | Pentacyclic taxan compound | |
| MA27610A1 (fr) | Derives d'acylaminothiazole, leur preparation et leur utilisation en tant qu'inhibiteurs de la production du peptide beta-amyloide | |
| DK1490391T3 (da) | 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring | |
| EA200000261A3 (ru) | Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция | |
| ATE342906T1 (de) | Tumorhemmende cerverbindungen | |
| BRPI0410056A (pt) | intermediários de imidazopiridina |